scholarly journals Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma

2021 ◽  
Vol 10 (23) ◽  
pp. 5499
Author(s):  
Susanne Ghandili ◽  
Martin Schönlein ◽  
Christian Wiessner ◽  
Heiko Becher ◽  
Marc Lütgehetmann ◽  
...  
Keyword(s):  
B Lymphocytes ◽  
Healthy Subjects ◽  
Control Group ◽  
Serological Response ◽  
Blood Samples ◽  
High Effectiveness ◽  
Boost Vaccination ◽  
Vaccination Response ◽  
Healthy Control ◽  
Antibody Titers

Even though several SARS-CoV-2 vaccines have shown high effectiveness in the prevention of COVID-19 in healthy subjects, vaccination response in patients with plasma-cell-related disorders (PCD) remains widely unknown. Here, we report on an analysis describing the serological response after prime-boost SARS-CoV-2 vaccination in PCD patients, as compared to a healthy control group, and on possible influencing factors of serological responses. Blood samples were analyzed for the presence of quantitative anti-SARS-CoV-2 spike RBD Ig. A total of 82 patients were included; 67 received mRNA-, eight vector-based and four heterologous vaccinations. SARS-CoV-2 antibody titers (SP-AbT) were assessed in a mean of 23 days (SD ± 11 days) after the first and in a mean 21 days (SD ± 9) after prime-boost vaccination. A positive SP-AbT was detected in 31.9% of PCD patients after the first vaccination, and in 88.9% (44/49) after prime-boost vaccination, which was significantly less likely than that in the control group (100%, 78/78) (p = 0.008). Furthermore, we have been able to validate our previously suggested threshold of 30 CD19+ B lymphocytes/µL as being predictive for SP-AbT development. Despite anti-CD38 directed therapy, quadruplet treatment, higher age and missing deep remission, which correlated negatively with SP-AbT appearance, SP-AbT formation is possible in a majority of myeloma patients after prime-boost vaccination.

scholarly journals Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients

Cephalalgia ◽  
2013 ◽  
Vol 33 (13) ◽  
pp. 1085-1095 ◽  
Author(s):  
Bernadett Tuka ◽  
Zsuzsanna Helyes ◽  
Adrienn Markovics ◽  
Teréz Bagoly ◽  
János Szolcsányi ◽  
...  
Keyword(s):  
Adenylate Cyclase ◽  
Healthy Subjects ◽  
Disease Duration ◽  
Animal Experiments ◽  
Control Group ◽  
Trigeminovascular System ◽  
Blood Samples ◽  
Calcitonin Gene ◽  
Pituitary Adenylate Cyclase ◽  
Healthy Control

Background Recent studies on migraineurs and our own animal experiments have revealed that pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38) has an important role in activation of the trigeminovascular system. The aim of this study was to determine the PACAP-38-like immunoreactivity (LI) in the plasma of healthy subjects, and parallel with the calcitonin gene-related peptide (CGRP)-LI in migraine patients in the ictal and interictal periods. Methods A total of 87 migraineurs and 40 healthy control volunteers were enrolled in the examination. Blood samples were collected from the cubital veins in both periods in 21 patients, and in either the ictal or the interictal period in the remaining 66 patients, and were analysed by radioimmunoassay. Results A significantly lower PACAP-38-LI was measured in the interictal plasma of the migraineurs as compared with the healthy control group ( p < 0.011). In contrast, elevated peptide levels were detected in the ictal period relative to the attack-free period in the 21 migraineurs ( pPACAP-38 < 0.001; pCGRP < 0.035) and PACAP-38-LI in the overall population of migraineurs ( p < 0.009). A negative correlation was observed between the interictal PACAP-38-LI and the disease duration. Conclusion This is the first study that has provided evidence of a clear association between migraine phases (ictal and interictal) and plasma PACAP-38-LI alterations.

scholarly journals Sequential muscle activation in the hemiparetic arm

2004 ◽  
Vol 60 (2) ◽  
Author(s):  
C. Mucha
Keyword(s):  
Patient Group ◽  
Healthy Subjects ◽  
Muscle Activation ◽  
Deltoid Muscle ◽  
Middle Part ◽  
Control Group ◽  
Biceps Muscle ◽  
Significant Prolongation ◽  
Healthy Control ◽  
Simultaneous Activation

This study investigated the chronological activation sequence of multiple joint movements of the hemiparetic arm in patients with central hemiparesis compared to healthy test subjects.Twelve patients with central hemiparesis and eight healthy control subjects were studied. First, in rapid abduction movement of the upper limb, the electromyographic activities of the middle part of the deltoid muscle, the brachial biceps muscle and the extensor muscles of the fingers, were registered. Second, in rapid flexion of the arm, the electromyographic activities of the ventral part of the deltoid muscle, the brachial biceps muscle and the superficial flexor muscles of the fingers, were measured. From the EMG data registered, activation duration, activation latency and the innervation sequence were determined and compared between the patient group and the control group. In the patient group, a significant prolongation of the activation duration was shown only in abduction. However, the activation latency was significantly prolonged in both movements compared to healthy test subjects. In the innervation sequences, a simultaneous activation was most frequently shown in healthy subjects. In healthy subjects, the deltoid muscle also usually functioned as leading muscle, whereas there was sometimes a shift distally to the brachial biceps muscle in the hemiparetic patients. The speed of rapid multiple joint movements in hemiparetic extremities seems to be unaffected in certain movements (anteversion), in others (abduction) it seems to be significantly reduced. This, as well as the fact that the activation latency is significantly longer in the hemiparetic limbs should be taken into consideration when choosing rehabilitation exercises.

scholarly journals Urine CA-2 as a biomarker for diagnosis urinary stone and prediction of its complications

2020 ◽  
Author(s):  
Yuan-jing Leng ◽  
Hai-bin Zhou ◽  
Jiang-ling Fu ◽  
Wen-juan Wang
Keyword(s):  
Healthy Subjects ◽  
Characteristic Curve ◽  
Urinary Stone ◽  
Urinary Stones ◽  
Enzyme Linked Immunosorbent Assay ◽  
Control Group ◽  
Healthy Control ◽  
The Mean ◽  
The Difference ◽  
The Relationship

Abstract PURPOSECarbonic anhydrase-2 (CA-2) plays a role in mineralization and calcification in organism. Strong evidence suggests that CA-2 is associated with urolithiasis. However, the relationship between CA-2 and urinary stone remains unclear. The study aimed to assess the association of urine CA-2 (uCA-2) level and the potential risk of urinary stone.METHODSFrom March 2017 to November 2019, a prospective cohort study was conducted on patients with urinary stones and healthy subjects to determine the pretreatment uCA-2 level detection by Enzyme linked immunosorbent assay (ELISA). The difference of uCA-2 level between patients with urinary stones and healthy subjects was compared. Then comparison between stone patients with complications and without complications was carried out as well as correlation analysis to detect factors associated with biomarker expression.RESULTS118 patients with urinary stones were into urinary stones group and 42 healthy subjects were into healthy control group. The mean pretreatment uCA-2 level was significantly higher in patients with urinary stones group than healthy controls group (P=0.028). Furthermore, The uCA-2 level was positive correlation with urinary stones complications (R=0.379, P=0.000), especially pain complications (R=0.524, P=0.000) and hematuria complications (R=0.374, P=0.000). Receiver operating characteristic curve (ROC) analysis that a uCA-2 level threshold of 10.94 ng/mL had 83.67% sensitivity and 68.12% specificity for predicting urinary stones complications. CONCLUSIONSExcessive uCA-2 excretion is a major risk factor for urinary stone. Our findings suggested that uCA-2 may be used as an unappreciated biomarker for the diagnosis urinary stone in patients and to predict its complications.

scholarly journals 16 Standardized phytomolecules improve foot and mouth disease vaccine response in grower pigs

2019 ◽  
Vol 97 (Supplement_3) ◽  
pp. 16-17
Author(s):  
Alexandra Blanchard ◽  
Josselin le Cour Grandmaison ◽  
In Ho Kim ◽  
Yong Min Kim
Keyword(s):  
Foot And Mouth Disease ◽  
Viral Disease ◽  
Mouth Disease ◽  
Vaccine Response ◽  
Blood Samples ◽  
Vaccination Response ◽  
Foot And Mouth ◽  
Negative Effect ◽  
Antibody Titers ◽  
Antibody Levels

Abstract Foot and Mouth Disease (FMD) is a severe viral disease with significant economic impact. In endemic countries, livestock may be vaccinated. Standardized capsicum and turmeric oleoresins have demonstrated a boosting effect of vaccination in broiler, but little is known on their efficacy in swine. The objective of this trial was to evaluate the efficiency of these phytomolecules to improve FMD vaccine response in pigs. Cross-breed pigs (n = 120) with body weight of 24.6 kg were allotted into 3 groups of 40 pigs and assigned into 10 replicates from days 70 to 112 of age. Following treatments were applied: NS: no vaccination; FMD-NS: FMD vaccination; FMD-XT: FMD vaccination + supplementation of XT-N (4% capsicum + 4% turmeric oleoresins, Pancosma, Switzerland) at 125 g/ton in feed. The FMD vaccine (Omanisa + O3039 + A22 Iraq-strain, Merial) was injected at day 78. Blood samples were collected at days 88, 93, 98 and 103 to evaluate antibody levels. Growth performance was evaluated at day 112. Data were analyzed using the GLM procedure of SAS®. During the trial, non-vaccinated pigs (NS) did not display antibody titers against FMD, but vaccinated pigs (FMD-NS and FMD-XT) exhibited significant levels of FMD antibodies (P &lt; 0.05). Pigs of FMD-XT group showed significant higher antibody levels at day 93 (P &lt; 0.05), day 98 (P = 0.06) and day 103 (P &lt; 0.05) in comparison to FMD-NS pigs. It indicated significant improvement of FMD vaccine response in comparison to the vaccinated control. At 112 days, FMD-NS pigs were numerically lighter (53.46 kg) in comparison to non-vaccinated pigs (53.89 kg). However, FMD-XT pigs were heavier (54.51 kg) in comparison to NS pigs (+0.62 kg, P &gt;0.05) and FMD-NS pigs (+1.05 kg, P &lt; 0.05). These findings showed that standardized phytomolecules (XT-N) incorporated into pig diet significantly supported FMD vaccination response and alleviated its negative effect on growth.

scholarly journals Vitamin K2 Supplementation Does Not Affect Vitamin K-Dependent Coagulation Factors Activity in Healthy Subjects: A Pilot Study

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1843-1843
Author(s):  
Jing Tan ◽  
Ruijun Ren ◽  
Dan Xu
Keyword(s):  
Vitamin K ◽  
Healthy Subjects ◽  
Coagulation Factors ◽  
Vitamin K2 ◽  
Control Group ◽  
Healthy Population ◽  
Thrombin Time ◽  
Healthy Individuals ◽  
Significant Difference ◽  
Healthy Control

Abstract Objectives Vitamin K is generally regarded as a procoagulant drug with physicians, concerns have been raised about its effects on hemostasis in the healthy population. We aimed to investigate whether vitamin K2 affects activities of individual vitamin K dependent coagulation factors in healthy individuals without anticoagulation treatment. Methods Forty healthy volunteers between 25 and 40 years old were recruited. They received 90 μg of vitamin K2 every day for 30 days. Prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), international normalized ratio (INR), fibrinogen (FIB) levels and blood coagulation factors II, VII, IX, and X activity levels (F II : C, FⅦ : C, FⅨ : C,FⅩ : C), protein induced by vitamin K absence or antagonist-II (PIVKA-II), which is uncarboxylated prothrombin were measured at day 0, and day 30 after vitamin K2 administration. Plasma diluted 1:10 from vitamin K2 group and healthy control group were assayed for the activity of factors II, VII, IX, and X. Results PT, APTT, TT, and FIB did not show significant difference at day 30 when compared with baseline. The activities of coagulation factors II, VII, IX, and X was not significantly different with baseline (97.28 ± 12.42% vs. 99.96 ± 10.24%, P = 0.24 for F II: C; 76.12 ± 15.82% vs. 76.40 ± 12.33%, P = 0.92 for FⅦ: C; 97.65 ± 13.98% vs. 99.65 ± 13.30%, P = 0.47 for FⅨ: C; 89.18 ± 10.76% vs. 92.01 ± 10.46%, P = 0.1 for FⅩ: C) . PIVKA-II levels were not changed with 30 days vitamin K2 supplementation (21.62 ± 3.21 vs. 23.87 ± 2.65 mAU/ml, P = 0.16). After 30 days vitamin K2 administration, factor II, Ⅶ, Ⅸ, and Ⅹ activity of plasma diluted up to 10 times were proportionally decreased, and did not show significant difference with the healthy control without vitamin K2 exposure (10.32 ± 1.24% vs. 10.97 ± 1.55%, P = 0.38 for F II: C; 9.52 ± 2.94% vs. 9.14 ± 1.79%, P = 0.68 for FⅦ: C; 11.78 ± 2.12% vs.11.65 ± 1.54%, P = 0.87 for FⅨ: C; 8.22 ± 1.28% vs. 8.92 ± 1.13%, P = 0.21 for FⅩ: C). Conclusions Vitamin K2 supplementation at recommended dosage does not affect vitamin K-dependent coagulation factors activity in healthy subjects. Uncarboxylated prothrombin (PIVKA-II) in healthy individuals is not decreased with vitamin K supplementation. Funding Sources None.

Prognostic value of mean platelet volume on tinnitus

2015 ◽  
Vol 130 (2) ◽  
pp. 162-165 ◽  
Author(s):  
O Kemal ◽  
T Müderris ◽  
F Başar ◽  
G Kutlar ◽  
F Gül
Keyword(s):  
Mean Platelet Volume ◽  
Healthy Subjects ◽  
Clinical Findings ◽  
University Hospital ◽  
Control Group ◽  
Study Group ◽  
Pathophysiological Mechanism ◽  
Platelet Volume ◽  
Significant Difference ◽  
Healthy Control

AbstractObjective:This study aimed to determine whether there was any relationship between tinnitus and mean platelet volume.Methods:This retrospective study was conducted between January 2013 and January 2014 in Ankara Atatürk Hospital and Ondokuz Mayıs University Hospital, Turkey, on a study group of 86 patients with tinnitus and a control group of 84 healthy subjects. Mean platelet volume was recorded and comparisons were made between the two groups.Results:Mean (± standard deviation) platelet volume was 7.67 ± 0.83 μm3 in the study group and 7.28 ± 0.56 μm3 in the control group. There was a statistically significant difference in mean platelet volume between the tinnitus patients and the healthy subjects (p < 0.05).Conclusion:The clinical findings indicated that tinnitus patients had a higher mean platelet volume than the healthy control subjects; however, the pathophysiological mechanism remains unclear.

scholarly journals Evaluation of Cervical Dysfunctions in Temporomandibular Disorders

2021 ◽  
Author(s):  
Mustafa Çorum
Keyword(s):  
Neck Pain ◽  
Temporomandibular Disorders ◽  
Healthy Subjects ◽  
Healthy Control Group ◽  
Control Group ◽  
Pain Group ◽  
Pain Provocation ◽  
Significant Difference ◽  
Upper Cervical ◽  
Healthy Control

Objective: The purpose of this study is to investigate upper cervical segmental dysfunctions in female patients with chronic TMD with and without neck pain and to compare them with healthy subjects. Method: Patients admitted to our hospital with jaw pain were evaluated in this study, and a total of 152 patients and healthy subjects who met the inclusion criteria for the study were divided into 3 groups: TMD with neck pain (n = 94), TMD without neck pain (n = 28) and control (n = 30). Patients with myofascial pain (category I) or disc displacements (category II) were diagnosed based on the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) guidelines. Upper cervical segmental dysfunctions were identified using functional and pain provocation tests in patients with TMD and healthy subjects. Results: When patients with TMD were classified, there was a significant difference between TMD with neck pain (category I, 62.8%; category II, 37.2%) and TMD without neck pain (category I, 28.6%; category II, 71.4%) groups (p = 0.002). There was a statistically significant dysfunction [difference] in all upper cervical segments in favor of the TMD with neck pain group compared TMD without neck pain group and healthy control group (p < 0.05). 51.1% Occiput-C1, 81.9% C1-C2 and 53.2% C2-C3 segment dysfunction rates were detected in TMD with neck pain group. Conclusion: Upper cervical segmental dysfunction rate was higher in TMD group with neck pain than TMD without neck pain and healthy control group.

scholarly journals Analysis of Eyelid Blink Characteristics in Patients with Ptosis Using a Smartphone Camera

2021 ◽  
Vol 62 (7) ◽  
pp. 873-880
Author(s):  
Taesung Joo ◽  
Jin-Ho Joo ◽  
In-Ki Park ◽  
Jae-Ho Shin
Keyword(s):  
Receiver Operating Characteristic ◽  
Roc Curve ◽  
Healthy Subjects ◽  
Operating Characteristic ◽  
Control Group ◽  
Palpebral Fissure ◽  
Blink Rate ◽  
Healthy Controls ◽  
Healthy Control ◽  
Receiver Operating

Purpose: To compare eyelid blink characteristics between patients with ptosis and healthy controls using a smartphone camera. Methods: The ptosis group consisted of 20 senile aponeurotic ptosis patients with margin reflex distance1 ≤2.5 mm and the control group consisted of 10 healthy subjects without ptosis. The ptosis group was further divided into two groups based on an age cutoff of 70 years. Palpebral fissure height, levator function, margin reflex distance1, inter-blink interval, blink duration, blink rate, and blink velocity were measured and compared between the three groups based on photographs of the eyelids and videos of blinking taken with a smartphone camera. Results: The palpebral fissure height, levator function, margin reflex distance1, and blink velocity were lower in the ptosis groups than in the control group but these values did not differ between the two ptosis groups. The palpebral fissure height, levator function, and margin reflex distance1 were correlated with blink velocity. In the receiver operating characteristic (ROC) curve of blink velocity, the area under the receiver operating characteristic (AUROC) curve value was as high as 0.969 and the cut-off value was 32.36 mm/s. Conclusions: It is possible to analyze eyelid blink characteristics using a smartphone camera and the results confirmed that palpebral fissure height, levator function, margin reflex distance1, and blink velocity were lower in the senile aponeurotic ptosis group than in the healthy control group and were unaffected by age. Additionally, blink velocity is valuable for diagnosis of ptosis due to the correlation between the degree of ptosis, blink velocity, and the ROC curve of blink velocity.

Study on the Subtypes of Dendritic Cells and the Expression of T Cell Co-Stimulating Molecules (CD80, CD86, CD40) on Dendritic Cells and B Cells in the Peripheral Blood of SAA Patients.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 3753-3753
Author(s):  
Zonghong Shao ◽  
Meifeng Tu ◽  
Hong Liu ◽  
Guangsheng He ◽  
Jun Shi ◽  
...  
Keyword(s):  
T Cell ◽  
B Lymphocytes ◽  
Normal Control ◽  
Peripheral Blood ◽  
Active Phase ◽  
Control Group ◽  
Control Groups ◽  
Significant Difference ◽  
Healthy Control ◽  
Cd40 Expression

Abstract Objective To detect the quantities of monocyte-derived dendritic cell precursors (pDC1) and plasmacytoid dendritic cell precursors (pDC2) in peripheral blood mononuclear cells (PBMC) of severe aplastic anemia (SAA) patients before and after immune suppressive therapy (IST), the ratio of their pDC1 to pDC2, and the expression of T-cell co-stimulating molecules (CD80, CD86, CD40) on dentritic cells (DC) and B cells surface in the SAA patients’ peripheral blood. Methods with three-color monoclonal antibody labeling technology, the quantities and ratio of pDC1 and pDC2 in PBMC were detected in 26 patients with SAA at active phase,13 patients with SAA at recovery phase and 15 normal control respectively by FACS. The aforementioned merits of 10 SAA patients were tested before and 2 months after IST by FACS. By FACS, the expression of CD80, CD86 and CD40 on DC and B lymphocytes were detected in 16 patients with SAA and 15 normal controls. Results The percentages of total pDC, pDC1, pDC2 and the ratio of pDC1/pDC2 of controls (healthy people) were(0.72±0.32)%,(0.41±0.18)%,(0.30±0.21)%, 1.58±0.69 respectively, and those of the patients with SAA at active phase were(0.96±0.92)%,(0.67±0.65)%,(0.32±0.30)%,2.70±1.63 respectively. The differences were significant [pDC1 (P<0.05); pDC1/pDC2 ratio (P<0.01)]. The aforementioned merits of recuperating SAA patients decreased to (0.77±0.48)%,(0.43±0.37)%,(0.34±0.34)%,1.78±1.29 respectively, which were not significantly different from those of normal control group. The aforementioned merits of 10 SAA patients were(0.87±0.98)%,(0.35±0.30)%,2.65±1.27 before IST, and(0.24±0.28)%,(0.14±0.14)%,2.16±0.82 after IST, with significant decreases of pDC1 and pDC2 (P<0.05). The percentages of CD80, CD86 and CD40 expression on DC in peripheral blood of healthy control were(1.61±2.37)%,(11.97±12.18)%,(0.56±1.26)% respectively, and those of SAA patients were(9.14±12.89)%,(29.84±9.56)%,(7.04±11.99)% respectively. There was a significant difference of CD86 expression (p<0.05) between SAA patient and normal control groups. The percentages of CD19, CD80, CD86 and CD40 expression on lymphocytes in peripheral blood of healthy control group were (9.38±3.18)%,(2.57±1.51)%,(1.86±1.11)%,(7.34±4.21)% respectively, and those of SAA patients were(11.12±9.02)%,(5.17±2.72)%,(5.98±3.84)%,(8.85±9.95)% respectively. There were significant differences of CD80 and CD86 expressions (P<0.05, P<0.01) between SAA and control groups. The percentages of CD80, CD86 and CD40 expression on B lymphocytes of control were(28.22±12.32)%, 8.04±2.27% and(81.6±22.45)% respectively, and those of SAA patients were(23.06±14.9)%,(20.46±11.1)%,(81.57±21.14)% respectively. There was a significant difference of CD86 expression (p<0.05) between patient and control groups. Conclusion The pDC subtypes were abnormal and the percentage of pDC1 increased in SAA patients, which were associated with the state of this illness. DC and B Lymphocytes in SAA up-regulated the expression of T cell co-stimulating molecules (CD86) that draw the T lymphocyte abnormally activated.

Taste Sensitivity to Phenylthiourea Among Leprosy and Filarial Patients in Coastal Andhra Pradesh

1972 ◽  
Vol 21 (4) ◽  
pp. 332-336
Author(s):  
B.R. Busi
Keyword(s):  
Healthy Subjects ◽  
Andhra Pradesh ◽  
Healthy Control Group ◽  
Taste Sensitivity ◽  
Control Group ◽  
Normal Individuals ◽  
Significant Difference ◽  
Leprosy Patients ◽  
Healthy Control

SummaryTaste blindness for PTC has been studied in (a) 416 leprosy patients and 424 healthy subjects, and (b) 261 filarial patients and 136 normal individuals of both sexes. A significant difference was found between leprosy patients and the healthy control group in the proportion of nontasters (χ2 = 4.096, for 1 DF, P〈0.05). No significant difference could be observed between the filariasis and the control group (χ2 = 0.605, for 1 DF, P〉0.30).

Sign in / Sign up

Export Citation Format

Share Document